Drug
Solifenacin
Solifenacin: highest development phase Post-Market, developed by Astellas. 3 trial records tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Solifenacin succinate NCT01777217 | Post-Market | Over-Active Bladder |
| VESICARE | Approved | |
| Solifenacin NCT00852696 | Not Applicable | Overactive Bladder |
Latest
No recent events.
Follow Solifenacin on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.